Lovastatin augments sulindac-induced apoptosis in colon cancer cells and potentiates chemopreventive effects of sulindac
about
Most effective colon cancer chemopreventive agents in rats: a systematic review of aberrant crypt foci and tumor data, ranked by potencyAspirin: still learning about the wonder drugCancer chemoprevention: lessons learned and future directionsHMG-CoA reductase inhibitor mevastatin enhances the growth inhibitory effect of butyrate in the colorectal carcinoma cell line Caco-2Chemoprevention of colorectal cancerSevere imbalance of cell proliferation and apoptosis in the left colon and in the rectosigmoid tract in subjects with a history of large adenomasScreening and Development of New Inhibitors of FtsZ from M. TuberculosisGrowth inhibition and apoptosis induction of Sulindac on Human gastric cancer cells.Simvastatin induces derepression of PTEN expression via NFkappaB to inhibit breast cancer cell growth.Apoptosis: implications for inflammatory bowel disease.Colorectal cancer risk in relation to antidepressant medication use.Statin use is associated with a reduced incidence of colorectal cancer: a colonoscopy-controlled case-control study.Multitargeted low-dose GLAD combination chemoprevention: a novel and promising approach to combat colon carcinogenesis.Chemopreventive effects of Coltect, a novel dietary supplement, alone and in combination with 5-aminosalicylic acid in 1,2-dimethylhydrazine-induced colon cancer in rats.Differential effects of lovastatin on cisplatin responses in normal human mesothelial cells versus cancer cells: implication for therapy.Anti-angiogenic and anti-inflammatory effects of statins: relevance to anti-cancer therapyImpact of diet on prostate cancer: a review.MYC phosphorylation, activation, and tumorigenic potential in hepatocellular carcinoma are regulated by HMG-CoA reductaseMicroarray and biochemical analysis of lovastatin-induced apoptosis of squamous cell carcinomasStatin use and colorectal cancer risk according to molecular subtypes in two large prospective cohort studies.The impact of nutrition in urogenital cancersCyclooxygenase inhibition in cancer prevention and treatment.Statin use and the risk of colorectal cancer: a population-based case-control studySulindac, 3,3'-diindolylmethane and curcumin reduce carcinogenesis in the Pirc rat, an Apc-driven model of colon carcinogenesisConcomitant suppression of hyperlipidemia and intestinal polyp formation by increasing lipoprotein lipase activity in Apc-deficient mice.Statin use and cancer risk: an epidemiologic review.Chemoprevention of colorectal cancer: two steps forward, one step back?The effects of selected drugs and dietary compounds on proliferation and apoptosis in colorectal carcinoma.Melanoma and nonmelanoma skin cancer chemoprevention: A role for nicotinamide?Survivin down-regulation plays a crucial role in 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor-induced apoptosis in cancer.Mechanism of lovastatin-induced apoptosis in intestinal epithelial cells.Mutual amplification of apoptosis by statin-induced mitochondrial stress and doxorubicin toxicity in human rhabdomyosarcoma cells.Cyclooxygenase 2 inhibitors and colon cancer.Sterol-independent regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase in tumor cells.Lovastatin potentiates antitumor activity of doxorubicin in murine melanoma via an apoptosis-dependent mechanism.Isoprenoids responsible for protein prenylation modulate the biological effects of statins on pancreatic cancer cells.Differential preventive activity of sulindac and atorvastatin in Apc(+/Min-FCCC)mice with or without colorectal adenomas.Amine Containing Analogs of Sulindac for Cancer Prevention.Celecoxib and curcumin additively inhibit the growth of colorectal cancer in a rat model.Aspirin alone and combined with a statin suppresses eicosanoid formation in human colon tissue.
P2860
Q24650990-0F329360-F389-4B43-ADD2-5876464A9971Q28165768-0F9E9918-7144-4033-B975-600F7D463FCCQ28191856-7B9CD857-FF41-4030-A1DC-5376C0A84206Q28201997-5663934D-1801-477C-8DAA-AB384B5D92D9Q28222931-2723217F-4FD7-4439-96D6-27EA29E2F87EQ28345953-DD19856C-9426-4885-AF82-78B0AF7A8DFDQ28552872-3121974F-379D-46FC-8844-2E38EACD7878Q33183406-28FDC9EA-517B-4D3E-AA0A-F2A061AD5747Q33678607-2FC58793-35D6-4ACC-BCB2-C2C70A65962AQ34015892-DAA1A6CE-432E-47D3-9875-22D0C1565078Q34234319-298E0C3A-78C2-4E72-A2C1-3CE2B1411675Q34244183-30F01E7C-5135-4E05-8FD2-3F86CFACFD22Q34342182-560033F2-5D9D-49D1-BD99-847A7196AD79Q34409206-3312EE3A-9148-47D8-ACDE-4EA3FA6F113BQ34428844-A61C2D9E-89ED-48D8-B665-69A655EEE2D3Q34429244-538A99B0-A65F-4C70-814F-99DB25B8CC43Q34446767-EB53C03D-504E-4FB0-8ACD-B565189BBD98Q34687185-5DB8919A-2EEC-4B09-8EF2-AC2E7722B7D5Q34929092-1DB3F582-76F7-4A65-965C-F97EE7694F8DQ35332074-AA992B9B-18EF-44A5-962D-D2AEA7471540Q35582852-B6AB8CE5-9291-45E2-BDB7-32C0C49C9083Q35593965-F52435AC-694B-4F9D-A444-141EBD151218Q35627285-E7B3B79A-3EB1-407B-BDE0-A43FDCD244F3Q35763386-78F2EB09-4ECB-4E81-A056-3CF37E3C96A3Q36444964-FD60FDE3-7126-4583-95F3-528745994E50Q36508082-E3CBD000-BD80-4F8B-A18A-66FD8DEE9647Q36677468-BB14DF75-EC04-4248-8326-CE1167BB99C0Q38254576-019D9172-3DF2-4707-90EC-83A16B392BC9Q39417544-E1AB8975-2203-4880-8CB6-59322666A647Q40138577-935B7E2D-00D0-4877-B9A4-7F1BAB1AF936Q40744609-F670DFFA-8737-4635-948E-B3C08E681F67Q41844170-91D163CB-7927-4F58-9BA7-608692D52934Q42048754-D3775A68-CC05-4DF0-929C-32CC38902713Q43825793-BB00DB08-C67E-4F12-8550-8AA4067D7549Q44062588-DAC2F778-E752-4127-9425-6881AFEE40A7Q47137660-35FCC718-9F6B-4123-8C2A-224D2A4CC018Q50084342-A7669FF6-97EA-4FE1-9A33-E51648362A35Q50324421-E97D5D4E-25D8-47E6-B0A1-325F264D91ABQ50472616-8C82E7EF-E605-4228-BC26-6031A26F196FQ52809890-DCC67182-6C77-468A-8DE1-77F5730B855D
P2860
Lovastatin augments sulindac-induced apoptosis in colon cancer cells and potentiates chemopreventive effects of sulindac
description
1999 nî lūn-bûn
@nan
1999 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Lovastatin augments sulindac-i ...... preventive effects of sulindac
@ast
Lovastatin augments sulindac-i ...... preventive effects of sulindac
@en
Lovastatin augments sulindac-i ...... preventive effects of sulindac
@nl
type
label
Lovastatin augments sulindac-i ...... preventive effects of sulindac
@ast
Lovastatin augments sulindac-i ...... preventive effects of sulindac
@en
Lovastatin augments sulindac-i ...... preventive effects of sulindac
@nl
prefLabel
Lovastatin augments sulindac-i ...... preventive effects of sulindac
@ast
Lovastatin augments sulindac-i ...... preventive effects of sulindac
@en
Lovastatin augments sulindac-i ...... preventive effects of sulindac
@nl
P2093
P3181
P1433
P1476
Lovastatin augments sulindac-i ...... preventive effects of sulindac
@en
P2093
S Bhendwal
P304
P3181
P356
10.1016/S0016-5085(99)70342-2
P407
P577
1999-10-01T00:00:00Z